Project Details
Description
NF110: Open-label, Phase 1 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
| Status | Active |
|---|---|
| Effective start/end date | 4/23/20 → 8/15/25 |
Funding
- THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
- U.S. DEPARTMENT OF DEFENSE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.